"El Instituto Valenciano de Infertilidad nace en el año 1990 como la primera institución médica en España especializada íntegramente en Reproducción Humana. Desde entonces ha ayudado a nacer a más de 200.000 niños gracias a la aplicación de los más novedosos métodos de reproducción asistida. Esto ha sido posible gracias al trabajo de un equipo multidisciplinar integrado por más de 2.500 profesionales altamente especializados en Ginecología, Obstetricia, Genética, Biología, Andrología, Cirugía, Medicina Materno-Fetal, Anestesia, etc."

During the past decade, IVI MAdrid conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IVI MAdrid" #1 sponsor was "IVI Madrid" with 14 trials, followed by "Ferring Pharmaceuticals" with 6 trials sponsored, "Igenomix" with 2 trials sponsored, "Finox AG" with 1 trials sponsored and "Fundación IVI" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IVI MAdrid" #1 collaborator was "Instituto Valenciano de Infertilidad, IVI VALENCIA" with 3 trials as a collaborator, "IVI Madrid" with 2 trials as a collaborator, "Fundación IVI" with 1 trials as a collaborator, "Hospital Universitario La Fe" with 1 trials as a collaborator and "IVI Barcelona" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "IVI MAdrid" are "Infertility" (13 trials), "Infertility, Female" (4 trials), "In Vitro Fertilisation (IVF) Treatment" (2 trials), "Age Factors" (1 trials) and "All Patients Which Show a Gestational Sac in Their Uterus in the First US Are Included in This Study and Randomized." (1 trials). Many other conditions were trialed in "IVI MAdrid" in a lesser frequency.

Most popular intervention types in "IVI MAdrid" are "Drug" (17 trials), "Other" (4 trials), "Procedure" (3 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Barusiban" (2 trials), "Corifollitropin alfa" (2 trials), "Recombinant FSH" (2 trials) and "Resveratrol" (2 trials). Other intervention names were less common.

The vast majority of trials in "IVI MAdrid" are 26 trials for "Female" genders, 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "IVI MAdrid". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in IVI MAdrid, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in IVI MAdrid, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 5 trials that are defined as “Not Applicable".